8-K
Current Report
Viridian Therapeutics, Inc.\DE Filed Acc 0001193125-17-104161
Auditor change · Executive or director change
- Item 4.01 Changes in the registrant's certifying accountant
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading d368813d8k.htm…